| |
| |
|
| Insider
Information: |
Scheinberg David A |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
82,537 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$245,691 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
82,537 |
|
|
| Total
Value |
$245,691 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Progenics Pharmaceuticals Inc |
PGNX |
|
2019-07-01 |
56,185 |
2003-09-24 |
0 |
Premium* |
|
|
Contrafect Corp |
CFRX |
Director |
2014-07-28 |
15,770 |
|
0 |
Premium* |
|
|
SELLAS Life Sciences Group Inc |
SLS |
Director |
2024-01-22 |
10,582 |
2017-12-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
40 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CFRX |
Contrafect Corp |
Director |
– • – |
2014-07-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,770 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Director |
– • – |
2005-07-11 |
4 |
GA |
$0.00 |
$0 |
D/D |
468 |
24,181 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Director |
– • – |
2004-10-01 |
4 |
OE |
$5.69 |
$7,114 |
D/D |
1,250 |
17,963 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Director |
– • – |
2012-02-23 |
4 |
AS |
$10.00 |
$12,500 |
D/D |
(1,250) |
46,185 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Director |
– • – |
2012-02-23 |
4 |
OE |
$6.90 |
$8,625 |
D/D |
1,250 |
47,435 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Director |
– • – |
2004-08-03 |
4 |
OE |
$12.00 |
$15,300 |
D/D |
1,275 |
16,713 |
|
- |
|
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2022-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
1,900 |
2,082 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Director |
– • – |
2003-11-04 |
4 |
OE |
$5.33 |
$10,660 |
D/D |
2,000 |
0 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Director |
– • – |
2003-11-04 |
4 |
S |
$17.70 |
$35,400 |
D/D |
(2,000) |
0 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Director |
– • – |
2005-07-01 |
4 |
S |
$20.85 |
$41,700 |
D/D |
(2,000) |
23,713 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Director |
– • – |
2005-07-01 |
4 |
OE |
$4.00 |
$8,000 |
D/D |
2,000 |
25,713 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Director |
– • – |
2005-07-11 |
4 |
OE |
$23.00 |
$46,000 |
D/D |
2,000 |
23,713 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Director |
– • – |
2005-07-11 |
4 |
OE |
$4.00 |
$8,000 |
D/D |
2,000 |
25,713 |
|
- |
|
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
4,582 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Director |
– • – |
2003-12-18 |
4 |
OE |
$5.33 |
$18,655 |
D/D |
3,500 |
15,438 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Director |
– • – |
2003-11-03 |
4 |
OE |
$5.33 |
$21,320 |
D/D |
4,000 |
0 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Director |
– • – |
2003-11-03 |
4 |
S |
$18.00 |
$72,000 |
D/D |
(4,000) |
0 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Director |
– • – |
2003-11-05 |
4 |
S |
$16.50 |
$66,600 |
D/D |
(4,000) |
11,938 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Director |
– • – |
2003-11-05 |
4 |
OE |
$5.33 |
$21,320 |
D/D |
4,000 |
0 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Director |
– • – |
2004-12-22 |
4 |
S |
$17.00 |
$68,000 |
D/D |
(4,000) |
21,963 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Director |
– • – |
2006-02-27 |
4 |
OE |
$4.00 |
$20,000 |
D/D |
5,000 |
29,181 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Director |
– • – |
2006-02-27 |
4 |
AS |
$30.02 |
$150,100 |
D/D |
(5,000) |
24,181 |
|
- |
|
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2024-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
10,582 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Director |
– • – |
2007-10-03 |
4/A |
A |
$0.00 |
$0 |
D/D |
6,501 |
38,682 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Director |
– • – |
2007-10-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,504 |
38,685 |
0 |
- |
|
40 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
